Pivotal Role of FBXW4 in Glioma Progression and Prognosis
Related Experiment Video
Updated: Jun 11, 2025
Co-culture of Glioblastoma Stem-like Cells on Patterned Neurons to Study Migration and Cellular Interactions
Published on: February 24, 2021
Kun Chen1, Lei Pu2, Yuzuo Hui1
1Department of Neurosurgery LiaoCheng People's Hospital, Liaocheng 252000, Shandong, China.
Backgrounds:
Glioma stands as one of the most formidable brain tumor types, with patient outcomes remaining bleak even in the face of advancements in treatment modalities. FBXW4, a constituent of the F-box and WD repeat domain-containing protein family, is recognized for its participation in diverse cellular activities, including those related to tumor dynamics. Yet, the therapeutic relevance and specific role of FBXW4 in the context of glioma are not well defined. This study aims to elucidate the functional dynamics and significance of FBXW4 in glioma cases.
Methods:
This research undertook a comprehensive analysis of FBXW4's expression patterns and clinical relevance in glioma by harnessing data from the TCGA and GTEx databases.
Results:
The investigation revealed a distinct downregulation of FBXW4 in glioma tissues compared to normal brain counterparts, with a pronounced correlation between FBXW4 levels and disease severity. Intriguingly, FBXW4 expression inversely related to WHO tumor grades, with the most advanced grade IV gliomas exhibiting the lowest FBXW4 levels, whereas grade II tumors demonstrated the highest. Cases presenting with IDH1/2 mutations or 1p/19q codeletions were also associated with elevated FBXW4 levels. Furthermore, diminished FBXW4 expression aligned with an increased risk of mortality.
Conclusions:
The findings suggest that FBXW4 holds promise as a prognostic marker and a potential therapeutic avenue in glioma management. Nonetheless, future research is imperative to decode the intricate signaling pathways involving FBXW4 and to understand its broader clinical ramifications in glioma treatment paradigms.
Insights
FBXW4 protein is downregulated in glioma, correlating with higher tumor grade and poorer survival. Lower FBXW4 levels indicate increased mortality risk in brain tumor patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Glioma is a severe brain tumor with limited treatment options.
- FBXW4, involved in cellular processes, has an undefined role in glioma.
- Understanding FBXW4's function is crucial for glioma research.
Purpose of the Study:
- To investigate the expression and clinical significance of FBXW4 in glioma.
- To determine FBXW4's potential as a prognostic biomarker.
Main Methods:
- Utilized TCGA and GTEx databases for comprehensive analysis.
- Examined FBXW4 expression patterns in glioma tissues versus normal brain.
- Correlated FBXW4 levels with clinical parameters like tumor grade and mutations.
Main Results:
- FBXW4 expression is significantly downregulated in glioma tissues.
- Lower FBXW4 levels correlate with higher WHO tumor grades (e.g., grade IV).
- Reduced FBXW4 expression is linked to increased mortality risk and IDH1/2 mutations.
Conclusions:
- FBXW4 shows potential as a prognostic marker for glioma.
- Further research is needed to explore FBXW4's therapeutic implications.
- Deciphering FBXW4 signaling pathways is key for future glioma treatment strategies.
